Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.21.1
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows from Operating Activities    
Net Income (Loss) $ (90,357) $ 368,286
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:    
Depletion, Depreciation, Amortization and Accretion 31,221 61,809
Amortization of Debt Issuance Costs 1,014 1,461
Loss on Extinguishment of Debt 12,594 5,527
Amortization of Bond Premium on Long-term Debt (122) (321)
Deferred Income Taxes 0 210
Unrealized (Gain) Loss of Derivative Instruments 128,398 (344,398)
Loss on Contingent Consideration 125 0
Stock-Based Compensation Expense 769 1,079
Other (61) (57)
Changes in Working Capital and Other Items:    
Accounts Receivable, Net (23,694) 10,789
Prepaid and Other Expenses (1,037) (251)
Accounts Payable 5,057 (1,514)
Accrued Interest (2,588) (2,290)
Accrued Liabilities and Expenses 1,447 327
Net Cash Provided by Operating Activities 62,766 100,654
Cash Flows from Investing Activities    
Drilling and Development Capital Expenditures (33,331) (78,962)
Acquisition of Oil and Natural Gas Properties (1,790) (25,537)
Acquisition Deposit (17,500) 0
Purchases of Other Property and Equipment (51) 0
Net Cash Used for Investing Activities (52,672) (104,500)
Cash Flows from Financing Activities    
Advances on Revolving Credit Facility 109,000 25,000
Repayments on Revolving Credit Facility (378,000) (15,000)
Repurchases of Second Lien Notes due 2023 (280,249) (13,277)
Repayment of Unsecured VEN Bakken Note due 2022 (130,000) 0
Debt Issuance Costs Paid (11,607) (37)
Issuance of Common Stock 132,900 0
Issuance of Unsecured VEN Bakken Note 550,000 0
Restricted Stock Surrenders - Tax Obligations (837) (396)
Net Cash Used for Financing Activities (8,793) (3,710)
Net Increase (Decrease) in Cash and Cash Equivalents 1,301 (7,555)
Cash and Cash Equivalents - Beginning of Period 1,428 16,068
Cash and Cash Equivalents - End of Period $ 2,729 $ 8,512